article thumbnail

SQA Regulatory Surveillance Summary | Monthly Update 2022 – Spring

SQA

For Investigator Sites, the subject areas are Organizational Aspects, Informed Consent of Trial Participants, Review of Trial Participant Data, and Management of Investigational Medicinal Product(s). United States Food and Drug Administration (FDA) – Regulations and Guidances.

FDA 75
article thumbnail

Health Provider News – February 10, 2023

Hall Render

billion since pandemic U.S. leading cause of death is heart disease, Alabama’s matches that Alabama lawmakers put temporary hold on $1 billion contract for prison healthcare New rolling NICU a ‘game changer’ for critical babies in Alabama More than a dozen Alabama hospitals at immediate risk of closing; officials say hospitals suffer $1.5

article thumbnail

The BFDs – The Ten Best Prescription Drug/Medical Device Decisions of 2023

Drug & Device Law

Since the FDA requires pre-approval of any warnings about off-label uses, preemption at some point should have been pre-ordained under the Mensing ( 2011+1 ) independence principle, but off-label use did not really figure in Zofran ’s analysis. The FDA’s five reviews of teratogenic risk all came to the same conclusion.

FDA 105